Document Detail

A placebo-controlled trial of low-dose erythromycin to promote feed tolerance in preterm infants.
MedLine Citation:
PMID:  11529540     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: Low-dose erythromycin promoted gastric emptying and feed tolerance in premature infants at a lower gestational age than previously reported. Increased exposure to broad-spectrum antibiotics may not be free of risk. Further studies are recommended to assess its efficacy in premature infants with established feed intolerance.
J Oei; K Lui
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Acta paediatrica (Oslo, Norway : 1992)     Volume:  90     ISSN:  0803-5253     ISO Abbreviation:  Acta Paediatr.     Publication Date:  2001 Aug 
Date Detail:
Created Date:  2001-08-31     Completed Date:  2002-01-03     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  9205968     Medline TA:  Acta Paediatr     Country:  Norway    
Other Details:
Languages:  eng     Pagination:  904-8     Citation Subset:  IM    
Department of Newborn Care, Royal Hospital for Women and the School of Paediatrics, University of New South Wales, Sydney, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Double-Blind Method
Enteral Nutrition
Erythromycin / therapeutic use*
Gastrointestinal Agents / therapeutic use*
Gastrointestinal Diseases / drug therapy*
Gastrointestinal Motility / drug effects
Infant, Newborn
Infant, Premature, Diseases / drug therapy*
Reg. No./Substance:
0/Gastrointestinal Agents; 114-07-8/Erythromycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Transcutaneous bilirubinometry in preterm infants.
Next Document:  Brainstem size and function at term age in relation to later neurosensory disability in high-risk, p...